Paper36075321
NLRP3 leucine-rich repeats control induced and spontaneous inflammasome activation in cryopyrin-associated periodic syndrome.
Theodoropoulou K and 5 others. J Allergy Clin Immunol, 2023. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. NLRP3 leucine-rich repeats control induced and spontaneous inflammasome activation in cryopyrin-associated periodic syndrome. Papers, record 36075321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36075321
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- NLRP3 leucine-rich repeats control induced and spontaneous inflammasome activation in cryopyrin-associated periodic syndrome.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Inflammasomes | Major topic |
| Cryopyrin-Associated Periodic Syndromes | Major topic |
| Humans | |
| NLR Family, Pyrin Domain-Containing 3 Protein | |
| Leucine | |
| Gain of Function Mutation |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42099240 | Advances in understanding the NLRP3 inflammasome‑mediated mechanisms and therapeutic targets in diabetic nephropathy (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42099240 | PubMed |
| 41879501 | Diverse Scaffolds Facilitate NLRP3 Clustering and Inflammasome Formation in Response to Perturbations in Cell Homeostasis. | Bioessays | 2026 | https://conductscience.org/library/papers/41879501 | PubMed |
| 41580475 | Splicing-driven post-translational dysregulation: a new frontier for precision cancer medicine and immunotherapy. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/41580475 | PubMed |
| 41355544 | Next-Generation Probiotics in Allergy Therapy: Scientific Evidence and Clinical Applications. | Antiinflamm Antiallergy Agents Med Chem | 2026 | https://conductscience.org/library/papers/41355544 | PubMed |
| 41219086 | Post-translational modifications of NLRP3: to prime or not to prime? | Trends Immunol | 2026 | https://conductscience.org/library/papers/41219086 | PubMed |
| 41206040 | Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammation. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/41206040 | PubMed |
| 40325263 | Neutrophilic Urticarial Dermatosis: A Window into Systemic Inflammation and Autoimmune Disorders. | Clin Rev Allergy Immunol | 2025 | https://conductscience.org/library/papers/40325263 | PubMed |
| 40307577 | Updated insights into the molecular networks for NLRP3 inflammasome activation. | Cell Mol Immunol | 2025 | https://conductscience.org/library/papers/40307577 | PubMed |
| 39816134 | Revealing the dance of NLRP3: spatiotemporal patterns in inflammasome activation. | Immunometabolism (Cobham) | 2025 | https://conductscience.org/library/papers/39816134 | PubMed |
| 39195255 | Implication of the LRR Domain in the Regulation and Activation of the NLRP3 Inflammasome. | Cells | 2024 | https://conductscience.org/library/papers/39195255 | PubMed |
| 38668995 | Anti-inflammatory effect of Trichospira verticillata via suppression of the NLRP3 inflammasome in neutrophilic asthma. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/38668995 | PubMed |
| 38416826 | HSP90β controls NLRP3 autoactivation. | Sci Adv | 2024 | https://conductscience.org/library/papers/38416826 | PubMed |
| 38310392 | Targeting NLRP3 Inflammasome: Structure, Function, and Inhibitors. | Curr Med Chem | 2024 | https://conductscience.org/library/papers/38310392 | PubMed |
| 38146057 | The discovery of NLRP3 and its function in cryopyrin-associated periodic syndromes and innate immunity. | Immunol Rev | 2024 | https://conductscience.org/library/papers/38146057 | PubMed |
| 38022631 | A phospho-harmonic orchestra plays the NLRP3 score. | Front Immunol | 2023 | https://conductscience.org/library/papers/38022631 | PubMed |
| 37849728 | Natural products modulate NLRP3 in ulcerative colitis. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37849728 | PubMed |
| 37670126 | Targeting NLRP3 inflammasome for neurodegenerative disorders. | Mol Psychiatry | 2023 | https://conductscience.org/library/papers/37670126 | PubMed |
| 37370025 | The NLRP3 inflammasome: contributions to inflammation-related diseases. | Cell Mol Biol Lett | 2023 | https://conductscience.org/library/papers/37370025 | PubMed |
| 36553538 | Can Polymorphisms in NLRP3 Inflammasome Complex Be Associated with Postmenopausal Osteoporosis Severity? | Genes (Basel) | 2022 | https://conductscience.org/library/papers/36553538 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NLRP3 | 114548 | PubTator's text mining | https://conductscience.org/library/genes/114548 | NCBI Gene |
| SUGT1 | 10910 | PubTator's text mining | https://conductscience.org/library/genes/10910 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36075321
GET https://conductscience.org/api/papers/v1/36075321/authors